Manufacturing is underway and doses of Moderna's Spikevax 2024-2025 formula will be ready to ship as early as August, pending regulatory approval The most common solicited local adverse event for ...
There are at least 12 vaccines on the market already in application or in the last phases of their clinical trials, waiting to be endorsed by the health authorities of the United States, the European ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results